# Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers

> **NCT00419172** · PHASE1 · COMPLETED · sponsor: **Novartis** · enrollment: 22 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Deferasirox
- **DRUG:** Rifampicin

## Key facts

- **NCT ID:** NCT00419172
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2009-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00419172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00419172, "Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00419172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*